Evidence map›Paper›PMID 36060957›Full record

ReviewFrontiers in endocrinology2022

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.

Bharti Jaiswal, Akanksha Agarwal, Ashish Gupta

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. A pharmacoinformatic approach for studyingFrontiers in oncology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Targeting epigenetic regulators to overcome drug resistance in cancers.Signal transduction and targeted therapy · 2023
    Review
  17. Review
  18. The epigenetic function of androgen receptor in prostate cancer progression.Frontiers in cell and developmental biology · 2023
    Review
  19. Epigenetic (De)regulation in Prostate Cancer.Cancer treatment and research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Bharti JaiswalIntegrative Chemical Biology (ICB), Institute for Stem Cell Science and Regenerative Medicine (inStem), Bengaluru, India.
Akanksha AgarwalEpigenetics and Human Disease Laboratory, Centre of Excellence in Epigenetics (CoEE) Department of Life Sciences, Shiv Nadar University, Delhi, UP, India.
Ashish GuptaEpigenetics and Human Disease Laboratory, Centre of Excellence in Epigenetics (CoEE) Department of Life Sciences, Shiv Nadar University, Delhi, UP, India.
Shiv Nadar University · INInstitute for Stem Cell Biology and Regenerative Medicine · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and growth of a normal prostate gland, as well as its physiological functions, are regulated by the actions of androgens through androgen receptor (AR) signaling which drives multiple cellular processes including transcription, cellular proliferation, and apoptosis in prostate cells. Post-translational regulation of AR plays a vital role in directing its cellular activities

Indexed as

Lysine AcetyltransferasesProstatic NeoplasmsReceptors, AndrogenAcetylationAndrogensHistone AcetyltransferasesHumansMaleAndrogensHistone AcetyltransferasesLysine AcetyltransferasesReceptors, Androgenandrogen receptorGCN5HBO1lysine acetyltransferasesP300PCAFprostate cancerTIP60

Identifiers

PMID36060957
PMCPMC9428678
OpenAlexW4292265645

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.